Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume

About this update from Therma Bright Inc.

The Company Announces Shares for Debt Settlements Toronto, Ontario--(Newsfile Corp. - June 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce continued sales momentum for its Venowave mobile compression device in the United States, highlighted by additional follow-on orders from Horizon Health USA ("Horizon") and from Gen-X Med. Building on the rapid deployment of previous shipments, Horizon Health USA has placed a new order for 100 Venowave units. This brings Horizon's positive order history to a total of 300 units within just months of their initial adoption, demonstrating consistent clinician satisfaction and market adoption across Horizon's extensive vascular patient base. Further expanding Therma Bright's market footprint, Gen-X Med has placed a follow-on order for 50 Venowave units. This existing customer relationship reflects the broadening appeal and commercial traction of the Venowave technology across distinct medical distribution networks in the U.S. To meet this accelerated demand and prepare for upcoming sales, Therma Bright is actively organizing and streamlining its manufacturing logistics for the next phase of bulk component reordering, ensuring a seamless supply chain to support both current and pipeline orders. Rob Fia, CEO of Therma Bright, commented: "The positive order history from Horizon Health is a tremendous validation of Venowave's utility and market fit. Seeing a premier distributor repeatedly double down on their inventory proves that patients and clinicians are getting real value. Furthermore, Gen-X Med's additional order of 50 units shows that our traction is expanding into new channels. We are now aggressively managing our manufacturing logistics to ensure we are fully prepared for the next wave of reorders and upcoming sales volumes." Therma also announces that it has negotiated debt settlements with arm's length and non-arm's length creditors. Pursuant to the debt settlements, and subject to acceptance by the TSX Venture Exchange (the "TSXV"), the Company proposes to settle aggregate debt of $396,840 in consideration for which it will issue an aggregate of 6,614,000 common shares at a dee...

View stock analysis, news, and events for Therma Bright Inc.